Total Payments
$106,721
2024 Payments
$147.19
Companies
8
Transactions
161
Medicare Patients
894
Medicare Billing
$412,697
Payment Breakdown by Category
Other$85,705 (80.3%)
Travel$9,338 (8.7%)
Consulting$8,148 (7.6%)
Food & Beverage$3,497 (3.3%)
Education$32.98 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $85,705 | 39 | 80.3% |
| Travel and Lodging | $9,338 | 51 | 8.7% |
| Consulting Fee | $8,148 | 3 | 7.6% |
| Food and Beverage | $3,497 | 62 | 3.3% |
| Education | $32.98 | 6 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $101,171 | 133 | $0 (2024) |
| US WorldMeds, LLC | $5,204 | 12 | $0 (2018) |
| Indivior Inc. | $159.19 | 7 | $0 (2024) |
| Braeburn Inc. | $75.43 | 3 | $0 (2024) |
| Braeburn Pharmaceuticals, Inc. | $48.14 | 2 | $0 (2017) |
| Kaleo, Inc. | $24.09 | 2 | $0 (2018) |
| iRhythm Technologies, Inc. | $23.72 | 1 | $0 (2020) |
| Gilead Sciences Inc | $14.74 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $147.19 | 6 | Indivior Inc. ($83.23) |
| 2023 | $33.05 | 1 | Braeburn Inc. ($33.05) |
| 2022 | $13.39 | 1 | Alkermes, Inc. ($13.39) |
| 2021 | $3,004 | 4 | Alkermes, Inc. ($3,004) |
| 2020 | $2,990 | 7 | Alkermes, Inc. ($2,966) |
| 2019 | $44,275 | 61 | Alkermes, Inc. ($44,261) |
| 2018 | $24,548 | 41 | Alkermes, Inc. ($19,285) |
| 2017 | $31,711 | 40 | Alkermes, Inc. ($31,620) |
All Payment Transactions
161 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $37.27 | General |
| Category: OUD | ||||||
| 08/27/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: OUD | ||||||
| 07/31/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: CNS | ||||||
| 04/24/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Opioid Use Disorder | ||||||
| 04/10/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: OUD | ||||||
| 02/26/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: Opioid Use Disorder | ||||||
| 10/12/2023 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $33.05 | General |
| Category: Opioid Use Disorder | ||||||
| 11/18/2022 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: CNS | ||||||
| 11/23/2021 | Alkermes, Inc. | VIVITROL (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,200.00 | General |
| Category: CNS | ||||||
| 11/16/2021 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $111.58 | General |
| Category: CNS | ||||||
| 10/06/2021 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: CNS | ||||||
| 08/04/2021 | Alkermes, Inc. | VIVITROL (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $675.00 | General |
| Category: CNS | ||||||
| 05/22/2020 | Alkermes, Inc. | Vivitrol (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $540.00 | General |
| Category: CNS | ||||||
| 03/23/2020 | Alkermes, Inc. | Vivitrol (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| Category: CNS | ||||||
| 03/10/2020 | Alkermes, Inc. | Vivitrol (Drug) | Food and Beverage | In-kind items and services | $108.58 | General |
| Category: CNS | ||||||
| 03/10/2020 | iRhythm Technologies, Inc. | ZIO Patch (Device) | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/22/2020 | Alkermes, Inc. | Vivitrol (Drug) | Travel and Lodging | In-kind items and services | $70.42 | General |
| Category: CNS | ||||||
| 01/22/2020 | Alkermes, Inc. | Vivitrol (Drug) | Travel and Lodging | In-kind items and services | $60.00 | General |
| Category: CNS | ||||||
| 01/13/2020 | Alkermes, Inc. | Vivitrol (Drug) | Travel and Lodging | In-kind items and services | $87.14 | General |
| Category: CNS | ||||||
| 12/19/2019 | Alkermes, Inc. | VIVITROL (Drug) | Travel and Lodging | In-kind items and services | $95.00 | General |
| Category: CNS | ||||||
| 12/19/2019 | Alkermes, Inc. | VIVITROL (Drug) | Travel and Lodging | In-kind items and services | $62.11 | General |
| Category: CNS | ||||||
| 11/14/2019 | Alkermes, Inc. | VIVITROL (Drug) | Travel and Lodging | In-kind items and services | $109.82 | General |
| Category: CNS | ||||||
| 11/14/2019 | Alkermes, Inc. | VIVITROL (Drug) | Travel and Lodging | In-kind items and services | $40.87 | General |
| Category: CNS | ||||||
| 11/14/2019 | Alkermes, Inc. | VIVITROL (Drug) | Travel and Lodging | In-kind items and services | $30.00 | General |
| Category: CNS | ||||||
| 11/01/2019 | Alkermes, Inc. | VIVITROL (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,500.00 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 273 | 1,842 | $394,050 | $135,418 |
| 2022 | 3 | 280 | 1,718 | $337,510 | $118,752 |
| 2021 | 3 | 185 | 1,231 | $214,880 | $84,632 |
| 2020 | 4 | 156 | 1,299 | $222,630 | $73,895 |
Total Patients
894
Total Services
6,090
Medicare Billing
$412,697
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 95 | 754 | $191,550 | $54,372 | 28.4% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 108 | 758 | $113,700 | $46,162 | 40.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 70 | 330 | $88,800 | $34,884 | 39.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 121 | 886 | $203,370 | $62,911 | 30.9% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 117 | 732 | $109,700 | $44,855 | 40.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 42 | 100 | $24,440 | $10,986 | 44.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 83 | 648 | $124,540 | $46,781 | 37.6% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2021 | 83 | 547 | $82,050 | $33,991 | 41.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 19 | 36 | $8,290 | $3,861 | 46.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 78 | 830 | $149,400 | $44,188 | 29.6% |
| 80307 | Testing for presence of drug | Office | 2020 | 52 | 442 | $66,300 | $27,317 | 41.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 11 | 11 | $3,250 | $1,349 | 41.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 15 | 16 | $3,680 | $1,041 | 28.3% |
About Dr. Brian Oconnor, MD
Dr. Brian Oconnor, MD is a Addiction Medicine healthcare provider based in Woburn, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1912991522.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Oconnor, MD has received a total of $106,721 in payments from pharmaceutical and medical device companies, with $147.19 received in 2024. These payments were reported across 161 transactions from 8 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($85,705).
As a Medicare-enrolled provider, Oconnor has provided services to 894 Medicare beneficiaries, totaling 6,090 services with total Medicare billing of $412,697. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Addiction Medicine
- Other Specialties Addiction Medicine
- Location Woburn, MA
- Active Since 09/09/2005
- Last Updated 07/29/2025
- Taxonomy Code 2083A0300X
- Entity Type Individual
- NPI Number 1912991522
Products in Payments
- Vivitrol 380 mg (Drug) $50,906
- VIVITROL (Drug) $47,294
- Lucemyra/Lofexidine (Drug) $5,204
- Vivitrol (Drug) $2,971
- SUBLOCADE (Drug) $122.67
- BRIXADI (Drug) $75.43
- Probuphine (Drug) $48.14
- SUBOXONE SUBLINGUAL FILM (Drug) $36.52
- Evzio (Drug) $24.09
- ZIO Patch (Device) $23.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.